Furthermore, the high abundance of ERRα was frequently detected in many types of solid tumors (including colon, endometrium, bladder, ovary, breast, and prostate cancers), and its upregulation was associated with more aggressive phenotypes, drug resistance, and poor prognosis [20,27]. Here, ESRRA is linked to Familial prostate cancer.